Analysts Are Downgrading These 5 Pharmaceutical Stocks
In this article, we present the 5 pharmaceutical stocks that are being downgraded by analysts.
Checkmate Pharmaceuticals Inc. (CMPI)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Clough Capital Partners Charles Clough | 0 | $0 | 0% | |
| 2. | Sectoral Asset Management Jerome Pfund And Michael Sjostrom | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.04 | 7,224 | $43,632.96 | 815,734 | 2021-06-18 | Filing | |
| $6.18 | 3,578 | $22,112.04 | 808,510 | 2021-06-16 | Filing | |
| $6.97 | 25,001 | $174,256.97 | 804,932 | 2021-05-18 | Filing | |
| $12.15 | 3,484 | $42,330.60 | 746,711 | 2021-03-26 | Filing | |
| $12.35 | 10,036 | $123,944.60 | 743,227 | 2021-03-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.45 | 95,800 | $1,001,100.42 | 2,155,930 | 2022-05-16 | Filing | |
| $10.45 | 35,850 | $374,464.01 | 2,251,730 | 2022-05-13 | Filing | |
| $10.39 | 124,525 | $1,294,312.85 | 2,287,580 | 2022-05-12 | Filing | |
| $10.38 | 17,700 | $183,641.04 | 2,412,105 | 2022-05-11 | Filing | |
| $10.38 | 18,676 | $193,869.95 | 2,429,805 | 2022-05-10 | Filing |
Institutional Investors' Holdings
News See All
Hedge Fund and Insider Trading News: James Woodson Davis, Michael Novogratz, Farallon Capital Management, Twilio Inc (TWLO), HIVE Blockchain Technologies Ltd (HVBTF), and More
For little-known hedge-fund manager Jim Davis, 2020 is a career-defining year. The one-time analyst for famed hedge-fund manager Julian Robertson Jr.
Is Checkmate Pharmaceuticals (CMPI) A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towards Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) and determine whether it is a good investment right now.
Hedge Fund Resource Center Billionaire Hedge Funds
